This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015; 28(3-4):251-63. doi: 10.1515/jpem-2014-0384. PMID: 25581748.AnıkAÇatlıGAbacıABöberEMaturity-onset diabetes of the young (MODY): an update2015283-425163doi10.1515/jpem-2014-0384.PMID: 25581748Open DOISearch in Google Scholar
Nkonge KM, Nkonge DK, Nkonge TN. The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY). Clin Diabetes Endocrinol. 2020; 6:20. https://doi.org/10.1186/s40842-020-00112-5.NkongeKMNkongeDKNkongeTNThe epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY)2020620https://doi.org/10.1186/s40842-020-00112-5.10.1186/s40842-020-00112-5764048333292863Search in Google Scholar
Juszczak A, Pryse R, Schuman A, Owen KR. When to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management. Br J Gen Pract. 2016; 66(647): e457-e459. doi: 10.3399/bjgp16X685537.JuszczakAPryseRSchumanAOwenKRWhen to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management201666647e457e459doi10.3399/bjgp16X685537.Open DOISearch in Google Scholar
Murphy R. Monogenic diabetes and pregnancy. Obstet Med. 2015; 8(3): 114-120. doi: 10.1177/1753495X15590713.MurphyRMonogenic diabetes and pregnancy201583114120doi10.1177/1753495X15590713.Open DOISearch in Google Scholar
Misra S, Dornhorst A. Gestational Diabetes Mellitus: Primum Non Nocere. Diabetes Care. 2012; 35(9): 1811-1813. doi: 10.2337/dc12-0689.MisraSDornhorstAGestational Diabetes Mellitus: Primum Non Nocere201235918111813doi10.2337/dc12-0689.Open DOISearch in Google Scholar
Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012 Jul; 49(7): 433-6. doi: 10.1136/jmedgenet-2012-100918.ChangXWangKwANNOVAR: annotating genetic variants for personal genomes via the web2012Jul4974336doi10.1136/jmedgenet-2012-100918355633722717648Open DOISearch in Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May; 17(5): 405-24. doi: 10.1038/gim.2015.30.RichardsSAzizNBaleSBickDDasSGastier-FosterJet alACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology2015May17540524doi10.1038/gim.2015.30.Open DOISearch in Google Scholar
Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013; 13:59. https://doi.org/10.1186/1471-2431-13-59.FentonTRKimJHA systematic review and meta-analysis to revise the Fenton growth chart for preterm infants20131359https://doi.org/10.1186/1471-2431-13-59.10.1186/1471-2431-13-59363747723601190Search in Google Scholar
Gloyn AL, Odili S, Zelent D, Buettger C, Castleden HAJ, Steele AM et al. Insights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young. J Biol Chem. 2005; 280(14): 14105-13. doi: 10.1074/jbc.M413146200GloynALOdiliSZelentDBuettgerCCastledenHAJSteeleAMet alInsights into the structure and regulation of glucokinase from a novel mutation (V62M), which causes maturity-onset diabetes of the young2005280141410513doi10.1074/jbc.M41314620015677479Open DOISearch in Google Scholar
Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K et al. Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes. Diabetes Care. 2016 Nov; 39(11): 1879-1888. doi: 10.2337/dc16-0645.ShepherdMShieldsBHammersleySHudsonMMcDonaldTJColcloughKet alSystematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes2016Nov391118791888doi10.2337/dc16-0645.Open DOISearch in Google Scholar
Aloi C, Salina A, Minuto N, Tallone R, Lugani F, Mascagni A et al. Glucokinase mutations in pediatric patients with impaired fasting glucose. Acta Diabetol. 2017 Oct; 54(10): 913-923. doi: 10.1007/s00592-017-1021-y.AloiCSalinaAMinutoNTalloneRLuganiFMascagniAet alGlucokinase mutations in pediatric patients with impaired fasting glucose2017Oct5410913923doi10.1007/s00592-017-1021-y.Open DOISearch in Google Scholar
Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellanné-Chantelot C, Ellard S, Gloyn AL. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia Hum Mutat. 2009 Nov; 30(11): 1512-26. doi: 10.1002/humu.21110.OsbakKKColcloughKSaint-MartinCBeerNLBellanné-ChantelotCEllardSGloynALUpdate on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia2009Nov3011151226doi10.1002/humu.2111019790256Open DOISearch in Google Scholar
Arden C, Trainer A, de la Iglesia N, Scougall ET, Gloyn AL, Lange AJ et al. Cell biological assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity. Diabetes. 2007 Jul; 56(7): 1773-82. doi: 10.2337/db06-1151.ArdenCTrainerAde laIglesia NScougallETGloynALLangeAJet alCell biological assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity2007Jul567177382doi10.2337/db06-1151.Open DOISearch in Google Scholar
Ralph EC, Sun S. Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type. Biochemistry. 2009 Mar 24; 48(11): 2514-21. doi: 10.1021/bi900020n.RalphECSunSBiochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type2009Mar 244811251421doi10.1021/bi900020n.Open DOISearch in Google Scholar
Rhea JM, Molinaro R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol. 2014 Jan; 141(1): 5-16. doi: 10.1309/AJCPQ23GTT-MLAEVL.RheaJMMolinaroRPathology consultation on HbA(1c) methods and interferences2014Jan1411516doi10.1309/AJCPQ23GTT-MLAEVL.Open DOISearch in Google Scholar